Many People Who Used Google Plus–or, More Likely, Signed Up and Never Did–Eligible for Payout
Don’t get too excited: awards range from minuscule to meager.
Ryan Farrick is a freelance writer and small business advertising consultant based out of mid-Michigan. Passionate about international politics and world affairs, he’s an avid traveler with a keen interest in the connections between South Asia and the United States. Ryan studied neuroscience and has spent the last several years working as an operations manager in transportation logistics.
Don’t get too excited: awards range from minuscule to meager.
An assortment of lawsuits claiming that popular social media app TikTok violates children’s privacy laws have merged into a major legal action. According to National Public Radio, twenty separate but similar lawsuits—all filed over the past year and a half—have coalesced into a single suit seeking class action certification. The prospective class is comprised of
A coalition of immigration attorneys have filed a lawsuit challenging the Newark EOIR’s mandate that non-detainee hearings be held in person.
Ohio’s Gallia County jail is facing two separate lawsuits, both filed in federal court. According to The Associated Press, Gallia County Jail—located in Ohio’s southern tip—has come under intense scrutiny in the past several years. Four inmates escaped from the facility in 2019, while other prisoners and their family members have complained of regular mistreatment.
Arizona’s attorney general is leading a multi-state probe into whether Apple violated deceptive trade laws.
Tripadvisor’s CEO echoed concerns voiced by Congress: that Google is increasingly using its search algorithm to direct consumers to its own products, rather than the most relevant results.
The 9th Circuit Court of Appeals’s ruling has consequences that go beyond Judd’s individual case.
The cost of becoming a naturalized U.S. citizen will nearly double.
The president’s directive comes scarcely 10 days after the Supreme Court ordered the administration to resume processing DACA applications.
While pharmaceutical executives have so far refused to negotiate with the White House, experts say Trump’s orders may lack any real bite.